Nabór wniosków w 5 konkursie IMI2
- Patient perspective elicitation on benefits and risks of medicinal products, from development through the entire life cycle, to inform the decision-making process by regulators and health technology assessment bodies
- Diabetic kidney disease biomarkers (DKD-BM)
- Inflammation and ad: modulating microglia function – focussing on TREM2 and CD33
- Understanding the role of amyloid imaging biomarkers in the current and future diagnosis and management of patients across the spectrum of cognitive impairment (from pre-dementia to dementia)
- Evolving models of patient engagement and access for earlier identification of Alzheimer’s disease: phased expansion study
- From ApoE biology to validated Alzheimer’s disease targets
Źródło: www.granty-na-badania.com
Tagi: konkurs, lek, innowacje
wstecz Podziel się ze znajomymi